Systemic HER3 ligand-mimicking nanobioparticles enter the brain and reduce intracranial tumour growth - Nature Nanotechnology Delivering therapeutics to the brain is challenging because of the hard-to-cross blood–brain barrier. Here, the authors show that HER3, which is expressed on the surface of many metastatic tumours,…

Research : doi.org/10.1038/s415...
@springernature.com

#bloodbrainbarrier #brainmetastases #braintumours #cancerdrugdelivery #her3receptor #nanomedicine